Clinical trial
Vumerity (Diroximel Fumarate) Prospective MS Pregnancy Exposure Registry
NCT05658497 is registered in ClinicalTrials.gov with Biogen as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Vumerity (Diroximel Fumarate) Prospective MS Pregnancy Exposure Registry
- Lead sponsor
- Biogen
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- October 27, 2023
- Completion date
- July 6, 2032
- Enrollment
- 908 (estimated)
- Sites
- 8
Conditions
As the registry lists them; a condition with its own page is linked.